Dr. Blake Henchcliffe, MD

Dr. Henchcliffe practices at Oceans Behavioral Hospital - Lake Charles in Lake Charles, Louisiana, part of Oceans Healthcare.

Dr. Henchcliffe's NPI, 1982191409, was assigned on April 19, 2018. Dr. Henchcliffe graduated from McGovern Medical School in 2018. Dr. Henchcliffe holds Texas license S3532.

Dr. Henchcliffe's primary practice is Oceans Behavioral Hospital - Lake Charles, at 302 W McNeese St, Lake Charles, LA 70605 in Calcasieu Parish. The practice phone is (337) 474-7581.

Dr. Henchcliffe's primary practice is Oceans Behavioral Hospital - Lake Charles in Lake Charles, Louisiana, part of Oceans Healthcare. The medical group on file is Access TeleCare. Dmand AI also links Dr. Henchcliffe to 12 more medical groups, 6 group practices and clinics and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henchcliffe practices, 8 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Henchcliffe's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Henchcliffe is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Henchcliffe's licenses on file in 9 states: Texas, Arkansas, Florida, Louisiana, West Virginia, Alabama, Kansas, Mississippi and Kentucky.

Dmand AI lists bipolar disorder, dementia, depression, insomnia, psychological distress and psychoses among the conditions Dr. Henchcliffe treats.

CMS data shows 93 Medicare services from Dr. Henchcliffe across 2 procedure codes in 2024, for 43 Medicare patients. Medicare paid $6,819 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Dr. Henchcliffe in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have anxiety, and 75% have depression. 47% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henchcliffe's median patient age at 40, with 43% women.

In 2024, Dr. Henchcliffe wrote 1,402 Medicare Part D claims for 219 patients. 94% of them were for generic drugs. CMS names the drug for 1,027 of them, across 34 drugs with 11 or more claims each, at $9,854 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Henchcliffe for performance year 2024, reported through an alternative payment model (APM). Dr. Henchcliffe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Henchcliffe as offering telehealth.

Dmand AI links 3 papers to Dr. Henchcliffe in 2016. The most frequent topics are Hernia, Ventral, Herniorrhaphy and Patient Acceptance of Health Care. Dr. Henchcliffe's most frequent co-authors are Julie Lynn Holihan, MD, Lillian S. Kao, MD and Tien C. Ko, MD.

CMS Open Payments shows 48 general payments to Dr. Henchcliffe from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Axsome Therapeutics, Inc. paid the most, $296.

Dr. Henchcliffe graduated from McGovern Medical School in 2018.

Dr. Henchcliffe is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.